Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report)’s stock price traded up 5.4% during trading on Monday . The company traded as high as $0.40 and last traded at $0.39. 65,682 shares traded hands during mid-day trading, an increase of 437% from the average session volume of 12,232 shares. The stock had previously closed at $0.37.
Integrated BioPharma Trading Down 3.6 %
The firm has a market capitalization of $11.39 million, a P/E ratio of 18.80 and a beta of 0.62. The firm has a 50 day moving average price of $0.34 and a 200-day moving average price of $0.28.
About Integrated BioPharma
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Recommended Stories
- Five stocks we like better than Integrated BioPharma
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Must-Have ETFs Set to Dominate This Quarter
- How to Calculate Inflation Rate
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Invest in Blue Chip Stocks
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
